A membership fee stated as a number
The tirzepatide product page carries a comparison table with a row headed membership fee. This seller's two columns hold a zero; one competitor column holds a positive figure and the brand column holds a dash.
That is a better disclosure than the sentence most sellers write. Sixty-four of the one hundred and fifty-eight sellers here say nothing either way about a membership fee, and many of the rest say no hidden fees, which is a promise about surprises rather than an answer about a line item. A zero in a labelled row is a claim you can hold somebody to.
The page repeats it in prose underneath: pricing is transparent, the same at every dose, and there are no hidden membership fees.
The four figures in that table that are not its prices
The same table prints a starting price per month for three competitors and for a brand-name product. Those are other companies' numbers on this company's page, and a scrape that read the table row by row would bank all four as this seller's rates.
We did not. Only the two figures in this seller's own columns are recorded, and they match the treatment rail that renders on every page of the site, including the privacy policy.
This is worth flagging as a reading habit rather than as a criticism of the seller. Comparison tables are common on these sites and they are the single easiest way to record a false price.
The rest of the record
The privacy policy names the operating company with a full street address three times, gives a support email and two telephone numbers, and names the programme administrator as the brand alongside a pharmacy. That is a stronger identity disclosure than most.
No individual prescribing clinician is named. One hundred and eight of the one hundred and fifty-eight sellers here name nobody who prescribes. No service area is published; one hundred and fifteen of the one hundred and fifty-eight sellers here publish none.
Both prices are starting-from figures with no plan term stated anywhere, which is the standing weakness. The dose commitment is real, but the term commitment is invisible.
OBU Health's published pricing
| Medication | Price | Verified |
|---|---|---|
| Tirzepatide (compounded) | $239/mostarting from, per month; the product page states the price is the same at every dose | September 2026source |
| Semaglutide (compounded) | $190/mostarting from, per month, from the treatment rail that renders on the product page | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See OBU Health's current price →Good fit if
- Readers who want the membership answer as a number in a labelled row rather than a promise in a sentence.
- Buyers who want a published street address and telephone numbers attached to a telehealth brand.
- People who want the price to hold as the dose rises.
Look elsewhere if
- Anyone who takes a comparison table at face value; four of the figures in this one belong to other companies.
- Readers who need a plan term stated beside a price. Both figures are starting-from rates with no term.
- Buyers who want an individual prescribing clinician named, or a service-area list.
How this review was verified
- Re-read the tirzepatide product page and the privacy policy on 6 September 2026, comparing the requested path to the effective path and running a nonsense path against the host in the same run.
- Recorded only the two figures in this seller's own columns and excluded the three competitor figures and the brand-name figure printed beside them.
- Cross-checked both recorded figures against the site-wide treatment rail, which renders the same two numbers on the privacy policy page.
- Read the membership status off the table row and the supporting sentence rather than off a marketing strapline.
- Screened the operating entity and the brand name against FDA's live warning-letter record with a known letter as a positive control and a nonsense string as a negative control in the same pass. Neither returned a letter. Untitled letters are published separately and were not searched.